Divalproex Sodium Tablet, Extended Release
Product Images NDC 68788-4100

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68788-4100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium Er Tab 500mg (Container)

Label for Divalproex Sodium ER Tab 500 mg extended release oral tablets. The label indicates the product is generic for Depakote ER, displays warnings, storage instructions, and lots for patient directions in English and Spanish. Labeler shown is Preferred Pharmaceuticals, Inc., with a barcode and QR code present.*

FDA Label Image

Figure1 (Figure1)

A cumulative distribution plot comparing the percentage of patients against the percentage reduction in CPS rate for Divalproex Sodium Delayed-Release Tablets versus placebo. The graph shows improvement and worsening along the vertical axis, with Divalproex Sodium represented by a solid line and placebo by a dashed line.*

FDA Label Image

Figure2 (Figure2)

A line graph comparing the percentage reduction in CPS (Complex Partial Seizures) rate among patients using high dose versus low dose Divalproex Sodium delayed-release tablets. The y-axis represents the percentage reduction in CPS rate from -100% to 100%, with improvement and worsening indicated. The x-axis shows the percentage of patients from 0 to 100%. Two lines plot patient response for high dose (solid line) and low dose (dashed line) Divalproex Sodium extended-release tablets.*

FDA Label Image

Figure3 (Figure3)

A bar graph comparing placebo and Divalproex Sodium Extended-Release Tablets. The y-axis measures a numerical value from 0 to 1.2. The placebo bar shows a value of 0.6, and the Divalproex Sodium bar shows a higher value of 1.2, indicating a comparison of results between the two groups.*

FDA Label Image

Structure (Structure)

Chemical structure of Divalproex Sodium, showing the molecular arrangement including sodium ion and organic groups with carbon, hydrogen, and oxygen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.